Study on coronavirus mutation doesn't prove new strain is more infectious: Dr. Scott Gottlieb

A new, early study by researchers at the Los Alamos National Laboratory shows the coronavirus may be mutating and the new, dominant strain appears to be even more contagious. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss.

Dr. Scott Gottlieb on Wednesday urged caution about a new study that suggests the coronavirus has mutated, with the new, dominant strain appearing to be even more contagious.

“It doesn’t prove that this new strain is in fact more infectious,” Gottlieb said on CNBC’s “Squawk Box.”

According to researchers at the Los Alamos National Laboratory, the new strain of the coronavirus started to spread in Europe in early February and then migrated to other parts of the world, including the U.S. By the end of March, this new strain became the dominant form of the virus in the U.S. and Canada.

“The analysis could be confounded by the fact that this just became the dominant strain in Europe because it got into Europe early and then got into the United States from Europe,” argued Gottlieb, the former head of the U.S. Food and Drug Administration. “It really doesn’t prove anything.”

Gottlieb said the study, which has not yet been peer reviewed, is only based on computational analysis and therefore more work needs to be done. “We don’t have any other data to support it, including cell culture data.”

“We saw a change like this with Ebola and we initially thought that it also made Ebola more contagious and we actually had cell culture data to support it at that time,” said Gottlieb, a CNBC contributor who sits on the boards of Pfizer and biotech company Illumina. “We found that when we put it into animal studies, in fact the change in the virus didn’t change its contours at all, didn’t make it more infectious.”

Pfizer is developing a vaccine. If the study were to be proven correct, it may complicate vaccine development.

The Los Alamos researchers said the mutation was of “urgent concern” because of the more than 100 vaccines in the process of being developed to prevent Covid-19. Some vaccine researchers have been using the virus’s genetic sequences isolated by health authorities early in the outbreak, which began late last year in China.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

#CNBC
#CNBC TV

Видео Study on coronavirus mutation doesn't prove new strain is more infectious: Dr. Scott Gottlieb канала CNBC Television